Atlas Trials

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

Clinical trial NCT02292719 · COMPLETED

Trial details

NCT number
NCT02292719
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis C Virus Infection
Start date
2014-12-19
Primary completion
2017-07-14
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.